Abstract

The Alzheimer's Drug Discovery Foundation's 13th International Conference on Alzheimer's Drug Discovery was held on 10-11 September 2012 in Jersey City, NJ, USA. This meeting report provides an overview of Alzheimer's Drug Discovery Foundation-funded programs, ranging from novel biomarkers to accelerate clinical development to drug-discovery programs with a focus on targets related to neuroprotection, mitochondrial function, apolipoprotein E and vascular biology.

Highlights

  • The Alzheimer’s Drug Discovery Foundation’s 13th International Conference on Alzheimer’s Drug Discovery was held on 10–11 September 2012 in Jersey City, NJ, USA. This meeting report provides an overview of Alzheimer’s Drug Discovery Foundation-funded programs, ranging from novel biomarkers to accelerate clinical development to drug-discovery programs with a focus on targets related to neuroprotection, mitochondrial function, apolipoprotein E and vascular biology

  • A multitude of factors lead to the onset of neurodegenerative diseases, including mitochondrial dysfunction, altered lipid metabolism and dysregulation of intracellular trafficking and signaling pathways

  • Apolipoprotein E While the APOE4 allele was identified as a significant risk allele for late-onset Alzheimer’s disease (AD) in the early 1990s, to date there are no late-stage development programs targeting this pathological mechanism

Read more

Summary

Introduction

A multitude of factors lead to the onset of neurodegenerative diseases, including mitochondrial dysfunction, altered lipid metabolism and dysregulation of intracellular trafficking and signaling pathways. Diverse therapeutic targets and biomarkers for Alzheimer’s disease and related dementias: report on the Alzheimer’s Drug Discovery Foundation 2012 International Conference on Alzheimer’s Drug Discovery This meeting report provides an overview of Alzheimer’s Drug Discovery Foundation-funded programs, ranging from novel biomarkers to accelerate clinical development to drug-discovery programs with a focus on targets related to neuroprotection, mitochondrial function, apolipoprotein E and vascular biology.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.